ATAD2 and breast cancer: Analysis of microarray data using the KM Plotter tool showed that overexpression of ATAD2 (Figure 3G), E2F1 (Figure 3H), and FOXM1 (Figure 3I), each conferred significantly poorer recurrence-free survival in breast cancer patients.